1. Home
  2. PTCT
  3. PTCT News

Latest PTC Therapeutics Inc. (PTCT) News on October 6, 2024

PTCT

MT Newswires

2 days ago

RBC Lifts Price Target on PTC Therapeutics to $34 From $32, Keeps Sector Perform Rating

3 Top Stocks That Could Still Rocket Higher in 2024
PTCT

Motley Fool

2 days ago

3 Top Stocks That Could Still Rocket Higher in 2024

PTCT

MT Newswires

5 days ago

PTC Therapeutics' New Drug Application for Phenylketonuria Treatment Sepiapterin Gets Accepted by FDA

PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients
PTCT

PR Newswire

5 days ago

PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients

5 FDA decisions to watch in the fourth quarter
PTCT

BioPharma Dive

5 days ago

5 FDA decisions to watch in the fourth quarter

PTCT

MT Newswires

10 days ago

PTC Therapeutics Granted FDA Fast Track Designation for Huntington's Disease Program

FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
PTCT

PR Newswire

10 days ago

FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTCT

PR Newswire

24 days ago

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics to Participate at Upcoming Investor Conferences
PTCT

PR Newswire

a month ago

PTC Therapeutics to Participate at Upcoming Investor Conferences

PTCT

MT Newswires

a month ago

ClearPoint Neuro Repays $10 Million Convertible Note Early

PTCT

MT Newswires

a month ago

PTC Therapeutics Has Upside Potential With Multiple Upcoming Catalysts, UBS Says

PTCT

MT Newswires

a month ago

UBS Upgrades PTC Therapeutics to Buy From Neutral, $47 Price Target

PTC Therapeutics Stock Earns RS Rating Upgrade To 83
PTCT

Investor's Business Daily

2 months ago

PTC Therapeutics Stock Earns RS Rating Upgrade To 83

PTC Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
PTCT

Simply Wall St.

2 months ago

PTC Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates
PTCT

Zacks

2 months ago

PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates

PTCT

Associated Press Finance

2 months ago

PTC Therapeutics: Q2 Earnings Snapshot

PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
PTCT

PR Newswire

2 months ago

PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

Unlocking Q2 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics
PTCT

Zacks

2 months ago

Unlocking Q2 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics

Crinetics Pharmaceuticals, Inc. (CRNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
PTCT

Zacks

2 months ago

Crinetics Pharmaceuticals, Inc. (CRNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

PTCT

MT Newswires

2 months ago

PTC Therapeutics Submits New Drug Application to US FDA for Metabolic Disorder Treatment

PTC Therapeutics Announces Sepiapterin NDA Submission to FDA
PTCT

PR Newswire

2 months ago

PTC Therapeutics Announces Sepiapterin NDA Submission to FDA

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
PTCT

PR Newswire

2 months ago

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know
PTCT

Zacks

2 months ago

Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know

PTCT

MT Newswires

3 months ago

RBC Cuts Price Target on PTC Therapeutics to $32 From $39, Keeps Sector Perform Rating

PTCT

MT Newswires

3 months ago

Cantor Fitzgerald Raises Price Target on PTC Therapeutics to $62 From $52, Maintains Overweight Rating

PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug
PTCT

Zacks

3 months ago

PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug

PTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble
PTCT

Investor's Business Daily

3 months ago

PTC's Journey Of 'Twist And Doubt' Continues With Another Rejection; Shares Tumble

PTCT

MT Newswires

3 months ago

Update: PTC Therapeutics Shares Drop After Negative Opinion on Muscular Dystrophy Treatment

PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again
PTCT

Investor's Business Daily

3 months ago

PTC Therapeutics Tumbles After European Regulators Reject Its Drug — Again

PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar
PTCT

BioPharma Dive

3 months ago

PTC faces another Duchenne drug rejection; Coherus sells Humira biosimilar

PTCT

MT Newswires

3 months ago

PTC Therapeutics Shares Drop After Negative Opinion on Muscular Dystrophy Treatment

CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review
PTCT

PR Newswire

3 months ago

CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review

PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
PTCT

Zacks

3 months ago

PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTCT

PR Newswire

3 months ago

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTCT

MT Newswires

4 months ago

BofA Securities Adjusts PTC Therapeutics Price Target to $32 From $25, Maintains Underperform Rating

PTCT

MT Newswires

4 months ago

PTC Therapeutics Reports Favorable Interim Results in Huntington's Disease Study; US FDA Lifts Clinical Hold

FDA lifts hold on PTC Huntington’s disease trial
PTCT

BioPharma Dive

4 months ago

FDA lifts hold on PTC Huntington’s disease trial

Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients
PTCT

PR Newswire

4 months ago

Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients

PTC Therapeutics to Participate at Upcoming Investor Conference
PTCT

PR Newswire

4 months ago

PTC Therapeutics to Participate at Upcoming Investor Conference

PTC Therapeutics Announces Validation of Sepiapterin European MAA
PTCT

PR Newswire

4 months ago

PTC Therapeutics Announces Validation of Sepiapterin European MAA

Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)
PTCT

GuruFocus.com

4 months ago

Insider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)

PTCT

MT Newswires

4 months ago

Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing

The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
PTCT

Zacks

4 months ago

The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics

Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
PTCT

Zacks

4 months ago

Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Forecasts
PTCT

Simply Wall St.

4 months ago

News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Forecasts

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug
PTCT

Zacks

4 months ago

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

PTCT

MT Newswires

5 months ago

Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating

PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'
PTCT

Investor's Business Daily

5 months ago

PTC Therapeutics Stock Soars As Its Biggest Drug 'Lives To Fight Another Day'

PTCT

MT Newswires

5 months ago

Raymond James Upgrades PTC Therapeutics to Market Perform From Underperform

PTCT

MT Newswires

5 months ago

Sector Update: Health Care

PTCT

MT Newswires

5 months ago

PTC Therapeutics Says European Commission Seeking Review of Negative Opinion on Translarna

European Commission, in ‘unprecedented’ move, declines to revoke approval of PTC Duchenne drug
PTCT

BioPharma Dive

5 months ago

European Commission, in ‘unprecedented’ move, declines to revoke approval of PTC Duchenne drug

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation
PTCT

PR Newswire

5 months ago

PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation

PTCT

MT Newswires

5 months ago

Sector Update: Health Care Stocks Steady Premarket Tuesday

PTCT

MT Newswires

5 months ago

Sector Update: Health Care

PTCT

MT Newswires

5 months ago

PTC Therapeutics Gets FDA Priority Review for Upstaza Biologics License Application

PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™
PTCT

PR Newswire

5 months ago

PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™

PTC Therapeutics to Participate at Upcoming Investor Conferences
PTCT

PR Newswire

5 months ago

PTC Therapeutics to Participate at Upcoming Investor Conferences

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
PTCT

Investor's Business Daily

5 months ago

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
PTCT

Insider Monkey

5 months ago

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript

PTCT

MT Newswires

5 months ago

Morgan Stanley Upgrades PTC Therapeutics to Equalweight From Underweight, Adjusts PT to $30 From $28

Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts
PTCT

Simply Wall St.

5 months ago

Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts

PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations
PTCT

Simply Wall St.

5 months ago

PTC Therapeutics First Quarter 2024 Earnings: Beats Expectations

PTCT

MT Newswires

5 months ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

PTCT

MT Newswires

5 months ago

PTC Therapeutics Shares Rise After Better-Than-Expected Q1 Results

PTCT

Thomson Reuters StreetEvents

5 months ago

Q1 2024 PTC Therapeutics Inc Earnings Call

PTCT

GuruFocus.com

5 months ago

PTC Therapeutics Inc (PTCT) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...

Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics
PTCT

Zacks

5 months ago

Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics

PTCT

GuruFocus.com

5 months ago

PTC Therapeutics Q1 2024 Earnings: A Detailed Financial Review

PTCT

Associated Press Finance

5 months ago

PTC Therapeutics: Q1 Earnings Snapshot

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
PTCT

PR Newswire

5 months ago

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTCT

PR Newswire

5 months ago

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
PTCT

Zacks

6 months ago

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results
PTCT

PR Newswire

6 months ago

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results

PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA
PTCT

PR Newswire

6 months ago

PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA

A Comprehensive Look at Sarepta's Growth and Innovation
PTCT

GuruFocus.com

6 months ago

A Comprehensive Look at Sarepta's Growth and Innovation

Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
PTCT

Zacks

7 months ago

Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More

PTC Therapeutics (PTCT) Up on Positive Regulatory Updates
PTCT

Zacks

7 months ago

PTC Therapeutics (PTCT) Up on Positive Regulatory Updates

PTC Therapeutics Provides Key Regulatory Updates
PTCT

PR Newswire

7 months ago

PTC Therapeutics Provides Key Regulatory Updates

PTC Therapeutics, Inc. (NASDAQ:PTCT) Just Released Its Yearly Earnings: Here's What Analysts Think
PTCT

Simply Wall St.

7 months ago

PTC Therapeutics, Inc. (NASDAQ:PTCT) Just Released Its Yearly Earnings: Here's What Analysts Think

PTC Therapeutics Full Year 2023 Earnings: EPS Misses Expectations
PTCT

Simply Wall St.

7 months ago

PTC Therapeutics Full Year 2023 Earnings: EPS Misses Expectations

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript
PTCT

Insider Monkey

7 months ago

PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript

PTCT

Thomson Reuters StreetEvents

7 months ago

Q4 2023 PTC Therapeutics Inc Earnings Call

Here's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings
PTCT

Zacks

7 months ago

Here's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings

PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates
PTCT

Zacks

7 months ago

PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates

PTCT

GuruFocus.com

7 months ago

PTC Therapeutics Inc (PTCT) Reports Robust Revenue Growth and Advances in Pipeline

PTCT

Associated Press Finance

7 months ago

PTC Therapeutics: Q4 Earnings Snapshot

PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PTCT

PR Newswire

7 months ago

PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

PTC Therapeutics to Participate at Upcoming Investor Conferences
PTCT

PR Newswire

7 months ago

PTC Therapeutics to Participate at Upcoming Investor Conferences

Wall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings
PTCT

Zacks

7 months ago

Wall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTCT

PR Newswire

7 months ago

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
PTCT

PR Newswire

8 months ago

PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results

Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know
PTCT

Zacks

8 months ago

Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know

PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
PTCT

Zacks

8 months ago

PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth

1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?
PTCT

Motley Fool

8 months ago

1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?

New H&M CEO Daniel Ervér 'concerned' about Red Sea disruptions
PTCT

Reuters

8 months ago

New H&M CEO Daniel Ervér 'concerned' about Red Sea disruptions

PTCT

GlobeNewswire

8 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30
PTCT

CNW Group

8 months ago

SmallRig Founder and Chairman Zhou Yang Recognized as One of Forbes China's Inaugural Globalization Innovators Top30

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research
PTCT

GlobeNewswire

8 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
PTCT

Barrons.com

8 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Share on Social Networks: